Research programme: sphingosine-1 phosphate receptor agonists - Pfizer
Alternative Names: 21-BW; S1P1 agonists - PfizerLatest Information Update: 16 Mar 2022
At a glance
- Originator Arena Pharmaceuticals
- Developer Pfizer
- Class Small molecules
- Mechanism of Action Sphingosine 1 phosphate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 11 Mar 2022 Arena Pharmaceuticals has been acquired and merged into Pfizer
- 28 May 2018 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA (PO)
- 09 May 2016 Preclinical development is ongoing in USA